Background. Factors determining predictability of response to thymectomy fo
r myasthenia gravis (MG) vary in the literature.
Methods. A 25-year retrospective review (1974 to 1999) of all thymectomies
performed at a single institution was undertaken.
Results. In 113 consecutive thymectomies for MG, women comprised 79% (89 of
113 patients), and mean age was 40 +/- 15 years. Complications occurred in
14% of patients (16 of 113). In-hospital mortality was 0, but 90-day hospi
tal mortality was 0.88% (16 of 113 patients). Follow-up was obtained in 81%
(92 of 113 patients) at a mean of 51 +/- 59 months postoperatively. Comple
te remission was achieved in 21% of patients (19 of 92), and marked improve
ment of MG in 54% (50 of 92), for a total benefit rate of 75%. Fourteen per
cent (13 of 92) were unchanged, and 11% (10 of 92) were worse. Using univar
iate analysis, sex, age, and pathology correlated significantly with outcom
e (p < 0.05): 80% of women (57 of 70) benefited from the procedure, versus
57% of men (12 of 21). Eighty percent (57 of 70) of patients less than 51 y
ears of age were improved or in remission, versus 57% (12 of 22) older than
50. Twenty-three percent (5 of 22) of patients with thymoma deteriorated,
versus 7.1% (5 of 70) without thymoma. Sex did not significantly correlate
in the multivariate model.
Conclusions. Sex, age, and thymic pathology are potential predictors of out
come in thymectomy for MG, and may shape treatment decisions and target hig
her-risk patients. (C) 2001 by The Society of Thoracic Surgeons.